{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.morvs.ai/drug-product/71390-011#drug","name":"BYFAVO","alternateName":"remimazolam besylate","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"71390-011"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"NDA212295"},{"@type":"PropertyValue","propertyID":"UNII","value":"280XQ6482H"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"4e1838f2-b999-41a7-a761-d94f09aa531f"}],"activeIngredient":"REMIMAZOLAM BESYLATE","administrationRoute":["INTRAVENOUS"],"dosageForm":"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION","manufacturer":{"@type":"Organization","name":"Acacia Pharma, Ltd."},"drugClass":[],"isAvailableGenerically":false,"legalStatus":"HUMAN PRESCRIPTION DRUG","sameAs":["https://api.morvs.ai/drug-approval/NDA212295","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4e1838f2-b999-41a7-a761-d94f09aa531f","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=71390-011"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-11-22T10:08:27.891Z"}}